Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | NTSR1 | P30989 | 8/20 | 0.57 |
| ▸ | NTSR2 | O95665 | 6/20 | 0.57 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.54 |
| ▸ | KDM1A | O60341 | 2/20 | 0.53 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | KDM5A | P29375 | 1/20 | 0.52 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 1/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30294171 | 0.93 | NTSR1 (0.64) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL30623611 | 0.93 | NTSR1 (0.65) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL30974622 | 0.92 | KDM1A (0.62) | NTSR1KDM1AMAOBKDM5AKDM1B | |
| SCHEMBL30286598 | 0.91 | NTSR1 (0.50) | NTSR1NTSR2SORT1KDM1ACALCRL | |
| SCHEMBL30390361 | 0.91 | NTSR1 (0.51) | NTSR1NTSR2SORT1KDM1ACALCRL | |
| SCHEMBL29940473 | 0.91 | NTSR1 (0.64) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL31151633 | 0.90 | NTSR1 (0.61) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL29414469 | 0.89 | NTSR1 (0.62) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL30361896 | 0.89 | NTSR1 (0.61) | NTSR1NTSR2SORT1OPRM1OPRD1 | |
| SCHEMBL31151650 | 0.89 | NTSR1 (0.49) | NTSR1NTSR2SORT1KDM1ANPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713002-A1 | PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA | Forssmann, Wolf-Georg (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4501348-A1 | PEPTIDES FOR USE IN THE IMPROVEMENT OF WELL-BEING | Forssmann, Wolf-Georg (DE) | 2025-02-05 | — | — | EP | disclosed |
| EP-4501347-A1 | PEPTIDES FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | Forssmann, Wolf-Georg (DE) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024235986-A1 | PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA | PHARIS BIOTEC GMBH (DE) | 2024-11-21 | — | — | WO | disclosed |
| WO-2024132726-A1 | SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE | UNIWERSYTET GDANSKI (PL) | 2024-06-27 | — | — | WO | disclosed |